Skip to content

cognitive dysfunction in type 2 diabetes mellitus patients

Prevalence of cognitive dysfunction in Type 2 diabetes mellitus patients in Indian population and understanding their possible link through targeted lipidomics approach

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/01/016877
Enrollment
1278
Registered
2019-01-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

None listed

Sponsors

Kasturba Medical College Manipal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1st objective:1) All T2DM patients above 20 years of age with informed consent visiting the hospital of various age groups ready to volunteer 2)Minimum of 5 years of formal education 3)Patients having all the co-morbidities including hypo and hyperthyroidism, hypertension, CAD, kidney and liver diseases, HIV, Vitamin B12 deficiency and any other infectious diseases 2nd objective- 1)T2DM patients above 60 years of age with more than 10 years of diabetes without any complications who are ready to volunteer with informed consent

Exclusion criteria

Exclusion criteria: 1st objective: 1)T2DM patients who are severely sick and unco-operative for performing the cognitive tests 2)Patients with visual impairment, confusion and delirium 3)Exclusion criteria for the 2ndobjective -T2DM patients suffering from hypo and hyper thyroidism, hypertension, HIV, Vitamin B12 deficiency, kidney, liver and other infectious diseases

Design outcomes

Primary

MeasureTime frame
Assessing cognitive dysfunction in type 2 diabetes mellitus patients and to find out whether there is a possibility of getting certain class of sphingolipids which may be up-regulated and down-regulated in T2DM patients suffering from CD. This information may be helpful for therapeutic intervention studies in future.Timepoint: one time

Secondary

MeasureTime frame
to find out whether there is a possibility of getting certain class of sphingolipids which may be up-regulated and down-regulated in T2DM patients suffering from CD. This information may be helpful for therapeutic intervention studies in future.Timepoint: one time

Countries

India

Contacts

Public ContactArpita Chakraborty

Kasturba Medical College Manipal, Manipal University

mm.prabhu@manipal.edu9449592986

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026